Information Technology Services
Compare Stocks
5 / 10Stock Comparison
NOTE vs CSGP vs VRSK vs MSCI vs ICE
Revenue, margins, valuation, and 5-year total return — side by side.
Real Estate - Services
Consulting Services
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
NOTE vs CSGP vs VRSK vs MSCI vs ICE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Real Estate - Services | Consulting Services | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $3M | $14.83B | $22.89B | $42.83B | $88.45B |
| Revenue (TTM) | $88M | $3.41B | $3.10B | $3.13B | $12.64B |
| Net Income (TTM) | $-105M | $25M | $910M | $1.32B | $3.30B |
| Gross Margin | 69.9% | 77.4% | 67.4% | 82.4% | 61.9% |
| Operating Margin | -74.9% | -0.8% | 44.9% | 54.7% | 38.7% |
| Forward P/E | — | 25.8x | 22.9x | 30.0x | 19.5x |
| Total Debt | $173M | $1.14B | $5.04B | $6.31B | $20.28B |
| Cash & Equiv. | $29M | $1.73B | $2.18B | $515M | $837M |
NOTE vs CSGP vs VRSK vs MSCI vs ICE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| FiscalNote Holdings… (NOTE) | 100 | 0.2 | -99.8% |
| CoStar Group, Inc. (CSGP) | 100 | 37.8 | -62.2% |
| Verisk Analytics, I… (VRSK) | 100 | 84.2 | -15.8% |
| MSCI Inc. (MSCI) | 100 | 131.8 | +31.8% |
| Intercontinental Ex… (ICE) | 100 | 135.4 | +35.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOTE vs CSGP vs VRSK vs MSCI vs ICE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOTE lags the leaders in this set but could rank higher in a more targeted comparison.
CSGP ranks third and is worth considering specifically for growth exposure.
- Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
- 18.7% FFO/revenue growth vs NOTE's -20.7%
Among these 5 stocks, VRSK doesn't own a clear edge in any measured category.
MSCI carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 7.2% 10Y total return vs ICE's 225.3%
- PEG 1.77 vs VRSK's 2.68
- Better valuation composite
- 38.4% margin vs NOTE's -119.0%
ICE is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 14 yrs, beta 0.33, yield 1.2%
- Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
- Beta 0.33, yield 1.2%, current ratio 1.02x
- Beta 0.33 vs NOTE's 2.79
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs NOTE's -20.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 38.4% margin vs NOTE's -119.0% | |
| Stability / Safety | Beta 0.33 vs NOTE's 2.79 | |
| Dividends | 1.2% yield, 14-year raise streak, vs MSCI's 1.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +7.8% vs NOTE's -97.4% | |
| Efficiency (ROA) | 24.0% ROA vs NOTE's -40.6%, ROIC 34.9% vs -0.1% |
NOTE vs CSGP vs VRSK vs MSCI vs ICE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOTE vs CSGP vs VRSK vs MSCI vs ICE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 2 of 6 categories
NOTE leads 1 • ICE leads 1 • CSGP leads 0 • VRSK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 143.7x NOTE's $88M. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to NOTE's -119.0%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $88M | $3.4B | $3.1B | $3.1B | $12.6B |
| EBITDAEarnings before interest/tax | -$54M | $278M | $1.7B | $2.0B | $6.5B |
| Net IncomeAfter-tax profit | -$105M | $25M | $910M | $1.3B | $3.3B |
| Free Cash FlowCash after capex | -$19M | $241M | $1.1B | $1.5B | $4.3B |
| Gross MarginGross profit ÷ Revenue | +69.9% | +77.4% | +67.4% | +82.4% | +61.9% |
| Operating MarginEBIT ÷ Revenue | -74.9% | -0.8% | +44.9% | +54.7% | +38.7% |
| Net MarginNet income ÷ Revenue | -119.0% | +0.7% | +29.3% | +38.4% | +26.1% |
| FCF MarginFCF ÷ Revenue | -21.2% | +7.1% | +36.3% | +49.4% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -27.2% | +22.5% | +3.9% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -6.0% | +127.7% | +4.8% | +49.1% | +23.1% |
Valuation Metrics
NOTE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 26.9x trailing earnings, VRSK trades at a 99% valuation discount to CSGP's 2107.2x P/E. Adjusting for growth (PEG ratio), MSCI offers better value at 2.23x vs VRSK's 3.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3M | $14.8B | $22.9B | $42.8B | $88.4B |
| Enterprise ValueMkt cap + debt − cash | $147M | $14.2B | $25.7B | $48.6B | $107.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.04x | 2107.23x | 26.92x | 37.81x | 27.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 25.84x | 22.85x | 29.99x | 19.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.16x | 2.23x | 3.05x |
| EV / EBITDAEnterprise value multiple | — | 83.74x | 15.34x | 25.17x | 16.71x |
| Price / SalesMarket cap ÷ Revenue | 0.03x | 4.57x | 7.45x | 13.67x | 7.00x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.77x | 78.44x | — | 3.08x |
| Price / FCFMarket cap ÷ FCF | — | 361.59x | 19.20x | 27.65x | 20.62x |
Profitability & Efficiency
MSCI leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-161 for NOTE. NOTE carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs NOTE's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -160.9% | +0.3% | +4.4% | — | +11.6% |
| ROA (TTM)Return on assets | -40.6% | +0.2% | +16.7% | +24.0% | +2.3% |
| ROICReturn on invested capital | -0.1% | -0.9% | +33.0% | +34.9% | +7.5% |
| ROCEReturn on capital employed | -0.0% | -0.8% | +39.6% | +44.3% | +9.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 5 | 8 | 9 |
| Debt / EquityFinancial leverage | 0.00x | 0.14x | 16.26x | — | 0.70x |
| Net DebtTotal debt minus cash | $144M | -$589M | $2.9B | $5.8B | $19.4B |
| Cash & Equiv.Liquid assets | $29M | $1.7B | $2.2B | $515M | $837M |
| Total DebtShort + long-term debt | $173M | $1.1B | $5.0B | $6.3B | $20.3B |
| Interest CoverageEBIT ÷ Interest expense | -2.58x | 1.58x | 7.87x | 7.67x | 6.53x |
Total Returns (Dividends Reinvested)
Evenly matched — MSCI and ICE each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ICE five years ago would be worth $14,335 today (with dividends reinvested), compared to $17 for NOTE. Over the past 12 months, MSCI leads with a +7.8% total return vs NOTE's -97.4%. The 3-year compound annual growth rate (CAGR) favors ICE at 14.7% vs NOTE's -78.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -87.4% | -46.7% | -20.7% | +4.5% | -2.1% |
| 1-Year ReturnPast 12 months | -97.4% | -53.6% | -43.0% | +7.8% | -10.4% |
| 3-Year ReturnCumulative with dividends | -99.0% | -52.9% | -14.5% | +28.6% | +50.8% |
| 5-Year ReturnCumulative with dividends | -99.8% | -58.9% | +1.8% | +27.9% | +43.4% |
| 10-Year ReturnCumulative with dividends | -99.8% | +77.5% | +137.1% | +720.9% | +225.3% |
| CAGR (3Y)Annualised 3-year return | -78.4% | -22.2% | -5.1% | +8.7% | +14.7% |
Risk & Volatility
Evenly matched — VRSK and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than NOTE's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 93.9% from its 52-week high vs NOTE's 2.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.79x | 0.80x | -0.04x | 0.61x | 0.33x |
| 52-Week HighHighest price in past year | $10.20 | $97.43 | $322.92 | $626.28 | $189.35 |
| 52-Week LowLowest price in past year | $0.15 | $33.31 | $161.70 | $501.08 | $143.17 |
| % of 52W HighCurrent price vs 52-week peak | +2.0% | +35.9% | +54.1% | +93.9% | +82.5% |
| RSI (14)Momentum oscillator 0–100 | 28.7 | 30.4 | 39.5 | 54.6 | 38.8 |
| Avg Volume (50D)Average daily shares traded | 492K | 5.9M | 1.9M | 520K | 3.0M |
Analyst Outlook
ICE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CSGP as "Buy", VRSK as "Hold", MSCI as "Buy", ICE as "Buy". Consensus price targets imply 77.0% upside for CSGP (target: $62) vs 14.6% for MSCI (target: $674). For income investors, ICE offers the higher dividend yield at 1.24% vs VRSK's 1.03%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $61.91 | $231.25 | $674.33 | $195.71 |
| # AnalystsCovering analysts | — | 25 | 25 | 27 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.0% | +1.2% | +1.2% |
| Dividend StreakConsecutive years of raises | — | — | 7 | 11 | 14 |
| Dividend / ShareAnnual DPS | — | — | $1.81 | $7.20 | $1.93 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.9% | +2.7% | +5.8% | +1.6% |
MSCI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NOTE leads in 1 (Valuation Metrics). 2 tied.
NOTE vs CSGP vs VRSK vs MSCI vs ICE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOTE or CSGP or VRSK or MSCI or ICE a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus -20. 7% for FiscalNote Holdings, Inc. (NOTE). Verisk Analytics, Inc. (VRSK) offers the better valuation at 26. 9x trailing P/E (22. 9x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOTE or CSGP or VRSK or MSCI or ICE?
On trailing P/E, Verisk Analytics, Inc.
(VRSK) is the cheapest at 26. 9x versus CoStar Group, Inc. at 2107. 2x. On forward P/E, Intercontinental Exchange, Inc. is actually cheaper at 19. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: MSCI Inc. wins at 1. 77x versus Verisk Analytics, Inc. 's 2. 68x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NOTE or CSGP or VRSK or MSCI or ICE?
Over the past 5 years, Intercontinental Exchange, Inc.
(ICE) delivered a total return of +43. 4%, compared to -99. 8% for FiscalNote Holdings, Inc. (NOTE). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus NOTE's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOTE or CSGP or VRSK or MSCI or ICE?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 04β versus FiscalNote Holdings, Inc. 's 2. 79β — meaning NOTE is approximately -7863% more volatile than VRSK relative to the S&P 500. On balance sheet safety, FiscalNote Holdings, Inc. (NOTE) carries a lower debt/equity ratio of 0% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NOTE or CSGP or VRSK or MSCI or ICE?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus -20. 7% for FiscalNote Holdings, Inc. (NOTE). On earnings-per-share growth, the picture is similar: Intercontinental Exchange, Inc. grew EPS 20. 7% year-over-year, compared to -660. 2% for FiscalNote Holdings, Inc.. Over a 3-year CAGR, CSGP leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOTE or CSGP or VRSK or MSCI or ICE?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus -68. 4% for FiscalNote Holdings, Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus -38. 9% for NOTE. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOTE or CSGP or VRSK or MSCI or ICE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, MSCI Inc. (MSCI) is the more undervalued stock at a PEG of 1. 77x versus Verisk Analytics, Inc. 's 2. 68x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Intercontinental Exchange, Inc. (ICE) trades at 19. 5x forward P/E versus 30. 0x for MSCI Inc. — 10. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 77. 0% to $61. 91.
08Which pays a better dividend — NOTE or CSGP or VRSK or MSCI or ICE?
In this comparison, ICE (1.
2% yield), MSCI (1. 2% yield), VRSK (1. 0% yield) pay a dividend. NOTE, CSGP do not pay a meaningful dividend and should not be held primarily for income.
09Is NOTE or CSGP or VRSK or MSCI or ICE better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). FiscalNote Holdings, Inc. (NOTE) carries a higher beta of 2. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VRSK: +137. 1%, NOTE: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOTE and CSGP and VRSK and MSCI and ICE?
These companies operate in different sectors (NOTE (Technology) and CSGP (Real Estate) and VRSK (Industrials) and MSCI (Financial Services) and ICE (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NOTE is a small-cap quality compounder stock; CSGP is a mid-cap high-growth stock; VRSK is a mid-cap quality compounder stock; MSCI is a mid-cap quality compounder stock; ICE is a mid-cap quality compounder stock. VRSK, MSCI, ICE pay a dividend while NOTE, CSGP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.